Trials / Sponsors / HotSpot Therapeutics, Inc
HotSpot Therapeutics, Inc
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer | Phase 1 / Phase 2 | 2023-03-15 |